IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
OTC Cough & Cold Medicine Manufacturing in the US - Market Size (2021-2031)
The market size of the OTC Cough & Cold Medicine Manufacturing industry in the US is $xx.xx, which is expected to grow at xx% over the next five years. Cough and cold manufacturers produce over-the-counter (OTC) medications formulated to relieve symptoms associated with coughs, colds, flu, congestion and related respiratory conditions. These products, including cough suppressants, expectorants and nasal decongestants, are available without a prescription. Manufacturers typically handle formulation, regulatory compliance, production, quality assurance, packaging, labeling and distribution to retail and pharmacy outlets.
Unlock the most recent data
Curious about what drives these trends? IBISWorld's OTC Cough & Cold Medicine Manufacturing in the US industry coverage has got you covered.
Market Size
Total value ($) and annual change from 2012 – 2030.
Revenue
$XX
2021-2026 XX%
2026-2031 XX%
Employees
XX
2021-2026 XX%
2026-2031 XX%
Businesses
XX
2021-2026 XX%
2026-2031 XX%
Profit
$XX
2021-2026 XX%
Profit Margin
$XX
2021-2026 XX%
Access this data your way
The OTC Cough & Cold Medicine Manufacturing in the US Industry Report is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
Industries related to this market
Explore industries with similar markets, supply chains, and economic drivers to gain broader context and insights.
Related Industries
Your industry answers engine
When the stakes are high, you need intelligence that cuts through the noise—wherever you work.
Frequently Asked Questions
What was the market size of the OTC Cough & Cold Medicine Manufacturing in the US in 2026?
The market size of the OTC Cough & Cold Medicine Manufacturing in the US is $12.3bn in 2026.
What is the growth rate of the OTC Cough & Cold Medicine Manufacturing in the US in 2026?
The market size of the OTC Cough & Cold Medicine Manufacturing in the US increased 1.6% in 2026.
Has the OTC Cough & Cold Medicine Manufacturing in the US grown or declined over the past 5 years?
The market size of the OTC Cough & Cold Medicine Manufacturing in the US has grown at a 2.1% CAGR between 2021 and 2026.
Is the OTC Cough & Cold Medicine Manufacturing in the US expected to grow or decline over the next five years?
See our full analysis of the OTC Cough & Cold Medicine Manufacturing in the US to understand if the industry market size is expected to grow or decline over the next five years.
Cut through the noise with intelligence you can trust
